Editor's Presentation: 'It takes a village to reduce cardiovascular risk'.

08:00 EDT 1st November 2019 | BioPortfolio

Summary of "Editor's Presentation: 'It takes a village to reduce cardiovascular risk'."

No Summary Available


Journal Details

This article was published in the following journal.

Name: European journal of preventive cardiology
ISSN: 2047-4881
Pages: 1799-1801


DeepDyve research library

PubMed Articles [22389 Associated PubMed Articles listed on BioPortfolio]

Gender inequalities for cardiovascular diseases.

Cardiovascular diseases are the primary cause of death in women. Cardiovascular risk is specific and often underestimated in women. At equal age, women have more cardiovascular risk factors than men. ...

It takes a village, but a village needs its leaders: An appreciation of Adele Wolfson.

Implementation of Early Peanut Introduction Guidelines: It Takes a Village.

A landmark study showed that early peanut introduction in high-risk infants, defined as infants with moderate to severe atopic dermatitis or egg allergy, reduced the risk of developing peanut allergy....

CV RISK - A new relative cardiovascular risk score.

Nowadays it is recommended to use risk scores to evaluate the magnitude of cardiovascular risk in healthy people, most popular being SCORE (Europe) and Framingham and ASCVD (US). Unfortunately, they a...

Rounding the corner on residual risk: Implications of REDUCE-IT for omega-3 polyunsaturated fatty acids treatment in secondary prevention of atherosclerotic cardiovascular disease.

Patients with established atherosclerotic cardiovascular (CV) disease remain at increased risk of major adverse cardiovascular events even during optimal lipid-lowering therapy. Recent studies using t...

Clinical Trials [11577 Associated Clinical Trials listed on BioPortfolio]

High Cardiovascular Risk Management and Salt Reduction in Rural Villages in China

Cardiovascular disease is the leading cause of death in China. At the village level, strategies for the control of cardiovascular disease are mostly absent. National clinical guidelines ...

Door-to-door Survey of Cardiovascular Health, Stroke and Ischemic Heart Disease in Atahualpa

The aim of the Atahualpa project is to evaluate the cardiovascular (CVH) status of the inhabitants of a rural village of coastal Ecuador as well as to determine the prevalence and retrospe...

Village-based vs Clinic-based ART Care - a Cluster Randomized Controlled Trial in Lesotho

This cluster-randomized trial tests a differentiated care model for patients newly tested HIV positive during home-based HIV testing in rural Lesotho, Southern Africa. In intervention clus...

The Effects of the Dietary Supplement CardioFlex Q10 on Reducing Cardiovascular Disease Risk Factors in Adults

Cardiovascular diseases (CVD), primarily heart disease and stroke, are the leading causes of death and prescription drug use in Canada. Research on certain dietary supplements looks promis...

A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities

This randomized, double-blind, placebo-controlled, parallel group, multicenter s tudy will evaluate the potential of aleglitazar to reduce cardiovascular risk in patients with stable cardi...

Medical and Biotech [MESH] Definitions

Efforts to reduce risk, to address and reduce incidents and accidents that may negatively impact healthcare consumers.

A specialty concerned with the nursing care of patients suffering from disorders of the CARDIOVASCULAR SYSTEM as well as those identified as at risk for adverse cardiac or vascular events.

A pyrrole and heptanoic acid derivative,HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; AND TRIGLYCERIDES and to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS and prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.

Restoration of functions to the maximum degree possible in a person or persons suffering from a CARDIOVASCULAR DISEASE. It also includes cardiac conditioning and SECONDARY PREVENTION in patients with elevated cardiovascular risk profile.

The application of methods designed to reduce the risk of harm associated with certain behaviors without reduction in frequency of those behaviors. The risk-associated behaviors include ongoing and active addictive behaviors.

Quick Search

DeepDyve research library

Relevant Topic

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Searches Linking to this Article